You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

teplizumab

Showing 1 - 17 of 17
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Type 1 Diabetes Trial (teplizumab)

Not yet recruiting
  • Type 1 Diabetes
  • teplizumab
  • (no location specified)
Mar 6, 2023

Type 1 Diabetes Trial (teplizumab or )

Terminated
  • Type 1 Diabetes Mellitus
  • teplizumab or placebo
  • (no location specified)
Feb 4, 2022

Psoriasis Trial in Ann Arbor, Portland (teplizumab)

Terminated
Has Results
  • Psoriasis
  • teplizumab
  • Ann Arbor, Michigan
  • +1 more
Feb 4, 2022

Type 1 Diabetes Trial in Atlanta (Teplizumab)

Terminated
  • Type 1 Diabetes Mellitus
  • Teplizumab
  • Atlanta, Georgia
    Atlanta Diabetes Associates
Feb 4, 2022

Diabetes, Type 1 Trial in United States (teplizumab)

Recruiting
  • Diabetes Mellitus, Type 1
  • teplizumab
  • Aurora, Colorado
  • +4 more
Sep 14, 2021

Type 1 Diabetes Trial in United States (mAb hOKT3gamma1(Ala-Ala), Teplizumab, Placebo Arm)

Completed
Has Results
  • Type 1 Diabetes Mellitus
  • mAb hOKT3gamma1(Ala-Ala), Teplizumab
  • Placebo Arm
  • San Francisco, California
  • +3 more
Aug 11, 2021

Diabetes, Type 1 Trial in Belgium, United States (AG019 - Low Dose, Teplizumab, Placebo-AG019)

Completed
  • Diabetes Mellitus, Type 1
  • AG019 - Low Dose
  • +5 more
  • Birmingham, Alabama
  • +17 more
Nov 9, 2021

Recent-Onset Type 1 Diabetes Extension Study Evaluating

Enrolling by invitation
  • Type 1 Diabetes Mellitus
  • Teplizumab
  • Placebo
  • San Diego, California
  • +41 more
Jan 31, 2023

Autoantibody Positive, Non-diabetic Relatives at Risk for Type 1 Diabetes, High Risk Trial in Canada, Germany, United States

Completed
Has Results
  • Autoantibody Positive
  • +3 more
  • Teplizumab
  • Placebo infusion
  • San Francisco, California
  • +18 more
Jul 21, 2020

Type 1 Diabetes Trial in Worldwide (Teplizumab (MGA031), Placebo)

Completed
  • Type 1 Diabetes Mellitus
  • Teplizumab (MGA031)
  • Placebo
  • Birmingham, Alabama
  • +117 more
Feb 4, 2022

Type 1 Diabetes Trial in Worldwide (Teplizumab, Placebo)

Completed
  • Type 1 Diabetes Mellitus
  • Teplizumab
  • Placebo
  • Birmingham, Alabama
  • +114 more
Feb 4, 2022

Type 1 Diabetes Trial in Milan (Sitagliptin, Professional CGM)

Not yet recruiting
  • Type 1 Diabetes
  • Milan, Italy
    ASST FBF Sacco
Jun 14, 2022

Evolution of Pre Type 1 Diabetes With Adult ONset

Active, not recruiting
  • Type 1 Diabetes
  • Type 1 Diabetes Mellitus Maturity Onset
  • High genetic risk for type 1 diabetes
  • High gentic risk for Coeliac disease
  • Exeter, Devon, United Kingdom
    NIHR Exeter Clinical Research Facility (Royal Devon University H
Aug 16, 2023

Type 1 Diabetes Extension Study

Recruiting
  • Type 1 Diabetes Mellitus
  • +2 more
    • San Francisco, California
    • +11 more
    Sep 13, 2021

    Diabetes, Type 1 Trial in United States (biological, other, dietary supplement)

    Completed
    Has Results
    • Diabetes Mellitus, Type 1
    • Anti-CD3 mAb
    • +2 more
    • San Francisco, California
    • +6 more
    Apr 11, 2017

    Diabetes, Type 1 Trial in San Francisco, New York, Seattle (hOKT3gamma1(Ala-Ala))

    Terminated
    • Diabetes Mellitus, Type 1
    • San Francisco, California
    • +2 more
    Feb 6, 2017

    AbATE Follow-Up Study

    Completed
    • Diabetes Mellitus, Type 1
      • New Haven, Connecticut
        Church Street Research Unit
      Jan 12, 2018